Article Details

Pfizer's Hemophilia B Gene Therapy Pass The Late-Stage Study - BW Healthcare

Retrieved on: 2022-12-30 06:15:29

Tags for this article:

Click the tags to see associated articles and topics

Pfizer's Hemophilia B Gene Therapy Pass The Late-Stage Study - BW Healthcare. View article details on hiswai:

Excerpt

Pfizer's therapy, fidanacogene elaparvovec, is designed to help patients produce factor IX themselves after a one-time treatment, as opposed to ...

Article found on: bwhealthcareworld.businessworld.in

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up